25 research outputs found

    Lin28 Enhances Tissue Repair by Reprogramming Cellular Metabolism

    Get PDF
    SummaryRegeneration capacity declines with age, but why juvenile organisms show enhanced tissue repair remains unexplained. Lin28a, a highly conserved RNA-binding protein expressed during embryogenesis, plays roles in development, pluripotency, and metabolism. To determine whether Lin28a might influence tissue repair in adults, we engineered the reactivation of Lin28a expression in several models of tissue injury. Lin28a reactivation improved hair regrowth by promoting anagen in hair follicles and accelerated regrowth of cartilage, bone, and mesenchyme after ear and digit injuries. Lin28a inhibits let-7 microRNA biogenesis; however, let-7 repression was necessary but insufficient to enhance repair. Lin28a bound to and enhanced the translation of mRNAs for several metabolic enzymes, thereby increasing glycolysis and oxidative phosphorylation (OxPhos). Lin28a-mediated enhancement of tissue repair was negated by OxPhos inhibition, whereas a pharmacologically induced increase in OxPhos enhanced repair. Thus, Lin28a enhances tissue repair in some adult tissues by reprogramming cellular bioenergetics.PaperCli

    Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma

    Get PDF
    Poor prognosis in neuroblastoma is associated with genetic amplification of MYCN. MYCN is itself a target of let-7, a tumour suppressor family of microRNAs implicated in numerous cancers. LIN28B, an inhibitor of let-7 biogenesis, is overexpressed in neuroblastoma and has been reported to regulate MYCN. Here we show, however, that LIN28B is dispensable in MYCN-amplified neuroblastoma cell lines, despite de-repression of let-7. We further demonstrate that MYCN messenger RNA levels in amplified disease are exceptionally high and sufficient to sponge let-7, which reconciles the dispensability of LIN28B. We found that genetic loss of let-7 is common in neuroblastoma, inversely associated with MYCN amplification, and independently associated with poor outcomes, providing a rationale for chromosomal loss patterns in neuroblastoma. We propose that let-7 disruption by LIN28B, MYCN sponging, or genetic loss is a unifying mechanism of neuroblastoma development with broad implications for cancer pathogenesis.United States. National Institutes of Health (R01GM107536)Alex's Lemonade Stand FoundationHoward Hughes Medical InstituteBoston Children's Hospital. Manton Center for Orphan Disease ResearchNational Institute of General Medical Sciences (U.S.) (T32GM007753

    La desigualdad en la tenencia de la tierra: una comparación de los datos de los censos y de los registros de propiedad en el sur de Costa Rica en el siglo XX

    No full text
    Al menos desde el tiempo de Aristóteles, la desigualdad de la tierra ha sido vista como causa de revoluciones y disturbios sociales. La mayoría de las revoluciones del siglo XX han estado vinculadas con la desigualdad agraria. Este articulo no se centra en los asuntos de la desigualdad y la insurgencia per se, sino que examina mas bien una significativa pero pocas veces atendida cuestión epistemológica: la validez de los datos de los censos agrícolas que sustentan la mayor parte de las investigaciones comparativas sobre disturbios sociales rurales. Nuestro análisis emplea un rico conjunto de datos de censos computarizados a la par de los datos de los registros mercantil, de la propiedad y del catastro que nos permiten examinar la misma área física a través de lentes diferentes y en tiempos distintos. Los datos provienen del cantón de Coto Brus, Costa Rica, un área que estaba siendo colonizada durante el periodo para el cual disponemos de datos de los censos agrícolas. Mostramos que el uso aísla do, ya sea de los datos de los censos o de los datos del registro, para la estimación de la concentración de la tierra puede ser muy inexacto. Esto puede explicar por que investigaciones anteriores han conducido con frecuencia a conclusiones equivocadas

    Celiac artery occlusion from median arcuate ligament compression complicating a hemorrhagic duodenal ulcer repair

    No full text
    We present a case of a hemorrhagic duodenal ulcer complicated by occlusion of the celiac artery (CA) by acute median arcuate ligament (MAL) compression. Angiography revealed retrograde flow through the gastroduodenal artery (GDA) to the hepatic artery, with occlusion at the CA origin. This unique presentation required coordinated release of the MAL to reestablish antegrade CA flow before pyloroplasty and GDA ligation. The presence of preexisting MAL compression of the CA should be considered during the repair of bleeding duodenal ulcers through embolization or ligation of the GDA, because impaired CA perfusion could result in foregut ischemia

    LIN28 Regulates Stem Cell Metabolism and Conversion to Primed Pluripotency

    No full text
    The RNA-binding proteins LIN28A and LIN28B play critical roles in embryonic development, tumorigenesis, and pluripotency, but their exact functions are poorly understood. Here, we show that, like LIN28A, LIN28B can function effectively with NANOG, OCT4, and SOX2 in reprogramming to pluripotency and that reactivation of both endogenous LIN28A and LIN28B loci are required for maximal reprogramming efficiency. In human fibroblasts, LIN28B is activated early during reprogramming, while LIN28A is activated later during the transition to bona fide induced pluripotent stem cells (iPSCs). In murine cells, LIN28A and LIN28B facilitate conversion from naive to primed pluripotency. Proteomic and metabolomic analysis highlighted roles for LIN28 in maintaining the low mitochondrial function associated with primed pluripotency and in regulating one-carbon metabolism, nucleotide metabolism, and histone methylation. LIN28 binds to mRNAs of proteins important for oxidative phosphorylation and modulates protein abundance. Thus, LIN28A and LIN28B play cooperative roles in regulating reprogramming, naive/primed pluripotency, and stem cell metabolism.Howard Hughes Medical Institute; SysCODE (Systems-based Consortium for Organ Design Engineering); NIH [RL1DE019021, CA196631-01A1, 1U54GM114838-01, R01GM107536, P50GM099117, U01 HL100001, P01CA120964, S10RR032861, P30CA006516]; Mayo Clinic Foundation; Mayo Clinic Center for Individualized Medicine; Ellison Medical FoundationSCI(E)[email protected]
    corecore